Fevertree Drinks (FEVR): Molson Coors US distribution transition

This situation live

FEVR Fevertree Drinks

£1,019m · 938.0p · +5% since the first step

29 Jan 2026 · Transition progressing to plan, marketing upweighted · −6% until the next step In the US, the transition into Molson Coors' national distribution network is progressing to plan and, alongside an upweighted marketing investment, will provide a strong platform for 2026.

24 Mar 2026 · Largely embedded; about 400 regional distributors · −1% until the next step With the distributor transition largely embedded and incremental marketing investment planned to build through 2026, we see a clear pathway to accelerating revenue growth in our largest market.

9 Jun 2026 · Past transition; leveraging network, winning accounts · −4% until the next step The partnership with Molson Coors has continued to progress well, moving beyond the initial transition period and beginning to leverage the new network, with new account wins, increasing distribution

10 Sep 2026 · Momentum building; US revenue +11% cc, margin lower · +22% since Sales momentum built through the first half as Fever-Tree benefited from the increasing scale and capabilities of the Molson Coors network, supported by strong distributor engagement and enhanced merc

Segment turn

Molson Coors US distribution transition

Momentum building; US revenue +11% cc, margin lower

Every step · 4

29 Jan 2026 Transition progressing to plan, marketing upweighted – In the US, the transition into Molson Coors' national distribution network is progressing to plan and, alongside an upweighted marketing investment, will... ↗
24 Mar 2026 Largely embedded; about 400 regional distributors – With the distributor transition largely embedded and incremental marketing investment planned to build through 2026, we see a clear pathway to accelerating... ↗
9 Jun 2026 Past transition; leveraging network, winning accounts – The partnership with Molson Coors has continued to progress well, moving beyond the initial transition period and beginning to leverage the new network,... ↗
10 Sep 2026 Momentum building; US revenue +11% cc, margin lower – Sales momentum built through the first half as Fever-Tree benefited from the increasing scale and capabilities of the Molson Coors network, supported by... ↗

What is happening

Fevertree Drinks: Molson Coors US distribution transition – Momentum building; US revenue +11% cc, margin lower. ['Momentum building; US revenue +11% cc, margin lower']

In short: Fever-Tree moved US distribution to Molson Coors in early 2026. In H1 FY26 US revenue rose 11% at constant currency with gains in retail value share, helped by the first national US marketing campaign. US EBITDA margin fell to 6.2% from 8.1% on step-up in marketing investment.
Announced: 29 Jan 2026 · Transition progressing to plan, marketing upweighted
Latest: 10 Sep 2026 · Momentum building; US revenue +11% cc, margin lower
US revenue: £66.9m, +11% at constant currency, H1 FY26
US EBITDA: £4.1m (6.2% margin) vs £5.0m (8.1%) in H1 FY25
Marketing: First national US campaign, 'Bartender's Best Kept Secret'
Margin view: Company cites step-changes in guaranteed US profitability over the medium term

From the company's own announcements. Not investment advice.

Briefing Pro

New to Fevertree Drinks? Get up to speed in 2 minutes.

What it does, how it got here, what management promised and delivered – written from its own announcements.

Get the FEVR briefing →

Also at Fevertree Drinks 2 open

Insider conviction1 director buying – £348k in 1 buy Legal & regulatoryUK EPR levy provision – Legal challenge launched; £2.8m provision booked Insider conviction1 director buying – £790k in 2 buys · closed Capital returnReturn of capital and buyback programme – proposed · closed Insider conviction3 directors buying – £1,226k in 3 buys · closed Fevertree Drinks – company page →